We are live on
!
Find out more
BWA
Basecamp Wealth Advisors Portfolio holdings
AUM
$537M
This Fund
S&P 500
This Quarter
Est. Return
+18.83%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$537M
AUM Growth
+$54.1M
(+11%)
Cap. Flow
-$9.24M
Cap. Flow
% of AUM
-1.72%
Top 10 Holdings %
Top 10 Hldgs %
53.24%
Holding
2,015
New
2
Increased
654
Reduced
562
Closed
193
Avg Time Held
1.8
quarters
Top 10 Avg Time Held
2
quarters
Top 20 Avg Time Held
1.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$280K |
| 2 |
POSCO
PKX
|
+$177K |
| 3 |
SPDR Gold Trust
GLD
|
+$124K |
| 4 |
iShares Silver Trust
SLV
|
+$120K |
| 5 |
Devon Energy
DVN
|
+$109K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$2M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$1.6M |
| 3 |
iShares TIPS Bond ETF
TIP
|
+$1.37M |
| 4 |
BITW
Bitwise 10 Crypto Index ETF
BITW
|
+$531K |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
+$451K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 19.52% |
| 3 | Healthcare | 7.05% |
| 4 | Financials | 6.95% |
| 5 | Consumer Discretionary | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1526
Teva Pharmaceutical Industries Limited
TEVA
$46.1B
| $983 | ﹤0.01% |
29
| – | – |
2025 Q4
2 quarters
|
|
1527
Rogers Corp
ROG
$2.86B
| $982 | ﹤0.01% |
6
-2
| -25% | -$275 |
2025 Q4
2 quarters
|
|
1528
Ocular Therapeutix
OCUL
$1.53B
| $972 | ﹤0.01% |
99
+53
| +115% | +$480 |
2026 Q1
1 quarter
|
|
1529
TriCo Bancshares
TCBK
$1.68B
| $969 | ﹤0.01% |
18
| – | – |
2026 Q1
1 quarter
|
|
1530
Treace Medical Concepts
TMCI
$286M
| $959 | ﹤0.01% |
241
+13
| +6% | +$36 |
2026 Q1
1 quarter
|
|
1531
Wolverine World Wide
WWW
$1.58B
| $959 | ﹤0.01% |
58
-33
| -36% | -$558 |
2025 Q4
2 quarters
|
|
1532
SI-BONE Inc
SIBN
$810M
| $930 | ﹤0.01% |
57
+47
| +470% | +$672 |
2026 Q1
1 quarter
|
|
|
NFBK
1533
DELISTED
Northfield Bancorp
NFBK
| $928 | ﹤0.01% |
63
-36
| -36% | -$509 |
2025 Q4
2 quarters
|
|
1534
Bank of Marin Bancorp
BMRC
$449M
| $914 | ﹤0.01% |
33
+11
| +50% | +$287 |
2026 Q1
1 quarter
|
|
1535
Janux Therapeutics
JANX
$1.04B
| $906 | ﹤0.01% |
59
+44
| +293% | +$637 |
2025 Q4
2 quarters
|
|
1536
Usana Health Sciences
USNA
$274M
| $897 | ﹤0.01% |
42
+7
| +20% | +$132 |
2026 Q1
1 quarter
|
|
1537
Alector
ALEC
$202M
| $896 | ﹤0.01% |
446
+117
| +36% | +$251 |
2025 Q4
2 quarters
|
|
1538
Celldex Therapeutics
CLDX
$2.49B
| $893 | ﹤0.01% |
24
| – | – |
2025 Q4
2 quarters
|
|
1539
Alkermes
ALKS
$7B
| $891 | ﹤0.01% |
17
| – | – |
2026 Q1
1 quarter
|
|
1540
Gentherm
THRM
$962M
| $887 | ﹤0.01% |
26
+7
| +37% | +$225 |
2025 Q4
2 quarters
|
|
1541
Oportun Financial
OPRT
$384M
| $885 | ﹤0.01% |
155
+23
| +17% | +$123 |
2026 Q1
1 quarter
|
|
1542
Kearny Financial
KRNY
$589M
| $880 | ﹤0.01% |
93
+18
| +24% | +$148 |
2026 Q1
1 quarter
|
|
|
LPRO
1543
DELISTED
Open Lending Corp
LPRO
| $880 | ﹤0.01% |
283
+59
| +26% | +$121 |
2025 Q4
2 quarters
|
|
1544
Stoneridge
SRI
$192M
| $878 | ﹤0.01% |
120
| – | – |
2025 Q4
2 quarters
|
|
1545
QuidelOrtho
QDEL
$739M
| $876 | ﹤0.01% |
50
| – | – |
2025 Q4
2 quarters
|
|
1546
Orthofix Medical
OFIX
$370M
| $868 | ﹤0.01% |
95
+32
| +51% | +$353 |
2026 Q1
1 quarter
|
|
1547
Trupanion
TRUP
$1.03B
| $867 | ﹤0.01% |
35
| – | – |
2025 Q4
2 quarters
|
|
1548
ProFrac Holding
ACDC
$834M
| $866 | ﹤0.01% |
149
+86
| +137% | +$579 |
2026 Q1
1 quarter
|
|
1549
Fulgent Genetics
FLGT
$591M
| $862 | ﹤0.01% |
42
+23
| +121% | +$390 |
2026 Q1
1 quarter
|
|
1550
Parke Bancorp
PKBK
$387M
| $862 | ﹤0.01% |
26
+8
| +44% | +$246 |
2026 Q1
1 quarter
|
|
Similar funds
AW
RCP
FCM
SLC
MIM
MHR
SAS
HL
Basecamp Wealth Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Basecamp Wealth Advisors held 2,015 positions worth $537M, up 11% from $483M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Basecamp Wealth Advisors's Q2 2026 filing shows 2 new, 654 increased, 562 reduced and 193 closed positions. Its largest new stake was First Citizens BancShares: 3 shares worth $6.24K. The largest sale was Vanguard FTSE All-World ex-US ETF, an estimated $2M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 48% a quarter earlier, followed by Technology and Healthcare.
- Basecamp Wealth Advisors's largest Q2 2026 buy was First Citizens BancShares: 3 shares worth $6.24K.
- Basecamp Wealth Advisors added most to Fidelity Wise Origin Bitcoin Fund in Q2 2026, an estimated $280K increase.
- Basecamp Wealth Advisors's biggest Q2 2026 reduction was Vanguard FTSE All-World ex-US ETF, cutting an estimated $2M.
- Basecamp Wealth Advisors fully exited iShares TIPS Bond ETF in Q2 2026, selling an estimated $1.37M.
- Basecamp Wealth Advisors's ten largest holdings make up 53% of its $537M portfolio in Q2 2026.
- Basecamp Wealth Advisors opened 2 new positions and closed 193 in Q2 2026.
- Basecamp Wealth Advisors's portfolio value rose 11% quarter-over-quarter to $537M.
Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.